Finch Therapeutics Group Inc (FNCH)

$1.92 0.18 (8.57%)

16:00 EDT FNCH Stock Quote Delayed 30 Minutes

FNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q1 2024

By InvestorPlace Earnings May 13, 2024

Finch Therapeutics Gr just reported results for the first quarter of 2024.

FNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 28,421

Day's Range $1.92 - $2.07

52-Week Range $1.86 - $16.74

Dividend & Yield N/A (N/A)

FNCH Stock Predictions, Articles, and Finch Therapeutics Group Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Apr 24, 2023

We're starting off the week with the biggest pre-market stock movers that traders will want to keep an eye on for Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Apr 20, 2023

We're starting off the day with an overview of all the biggest pre-market stock movers worth watching on Thursday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Apr 19, 2023

It's time for another dive into the biggest pre-market stock movers traders will want to know about on Wednesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 11, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 24, 2022

Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

Why Is Finch Therapeutics (FNCH) Stock Up 30% Today?

By William White, InvestorPlace Writer Apr 29, 2022

Finch Therapeutics (FNCH) stock is rising higher on Friday following news that the FDA has released its clinical hold on CP101.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Apr 29, 2022

Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday!

Finch announces reverse stock split to regain Nasdaq compliance (NASDAQ:FNCH)

From Seeking Alpha Jun 9, 2023

Finch Therapeutics (FNCH) will effect a one-for-30 reverse stock split of its issued and outstanding common stock, effective opening of trading on June 12, The reverse stock split...

Finch Therapeutics brings on Roivant Sciences' Matthew Blischak as CEO (NASDAQ:FNCH)

From Seeking Alpha Apr 25, 2023

Finch Therapeutics (FNCH) on Tuesday said it had appointed Matthew Blischak as CEO, effective May 16. Read more on the executive change here.

Finch stock rises despite abandoning phase 3 trial, cutting ~95% workforce

From Seeking Alpha Jan 24, 2023

Finch Therapeutics (FNCH) is discontinuing a phase 3 trial of its bacterial infection drug CP101 and reducing workforce by ~95%.The company noted that it will discontinue the...

Analysts Are Bullish on These Healthcare Stocks: Kezar Life Sciences (KZR), RVL Pharmaceuticals (RVLP)

From TipRanks Nov 11, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kezar Life Sciences (

Analysts’ Top Healthcare Picks: Viridian Therapeutics (VRDN), Springworks Therapeutics (SWTX)

From TipRanks Aug 18, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Viridian Therapeutics (

Finch Therapeutics Cuts 20% Workforce, Realigns Focus On C. Diff, Autism Programs

From Benzinga Apr 20, 2022

ADVERTISEMENT